DOI QR코드

DOI QR Code

A Case of Cobra Antivenom Therapy in a Patient Bitten by Elapid Snake in South Korea

코브라과 뱀에 물린 환자에서 코브라 항독소를 사용하여 치료한 1례

  • Kim, Ji Eun (Department of Emergency Medicine, College of Medicine, Dong-A University) ;
  • Kwon, In Ho (Department of Emergency Medicine, College of Medicine, Dong-A University)
  • 김지은 (동아대학교병원 응급의학과) ;
  • 권인호 (동아대학교병원 응급의학과)
  • Received : 2022.01.22
  • Accepted : 2022.03.02
  • Published : 2022.06.30

Abstract

Elapid snakes have neurotoxic venom which causes diverse neuroparalytic manifestations, including fatal respiratory failure. In South Korea, since elapid snakebites are very rare, the cobra antivenom, which is effective against neurotoxicity, was only introduced recently. Most physicians in South Korea have little experience in the treatment of patients who have been bitten by elapid snakes. A 19-year-old man was brought to the emergency department with sudden diplopia, 1 hour after a snakebite on the left 2nd finger. The patient presented with drowsiness and complained of mild dizziness and binocular diplopia. After 1 hour, he had sudden onset of dyspnea and dysphagia and appeared to be agitated. He was immediately intubated and received mechanical ventilation as he was unable to breathe on his own. A total of 2.5 mg of neostigmine diluted with normal saline was slowly infused, and 1 vial of cobra antivenom was infused for an hour, 5 times every 2 hours, for a total of 5 vials. He slowly recovered self-breathing; on the 3rd day of hospitalization, he showed tolerable breathing and was extubated. He was discharged without any neurological deficits or other complications.

Keywords

Acknowledgement

The authors would like to thank the National Medical Center for providing cobra antivenom.

References

  1. Moon JM, Chun BJ, Cho YS, Kim JC, Koo YJ, Park KH, et al. Coagulopathy after snake envenomation in South Korea. Clin Toxicol (Phila). 2021;59:905-12. https://doi.org/10.1080/15563650.2021.1884694
  2. Lee SW, Jung IC, Yoon YH, Hong SH, Han KS, Choi SH, et al. Anticholinesterase therapy for patients with ophthalmoplegia following snake bites: report of two cases. J Korean Med Sci. 2004;19:631-3. https://doi.org/10.3346/jkms.2004.19.4.631
  3. Kakaria AS, Narkhede M, Agrawal S, Bhavsar A, Nukte V. A study of outcome of neuroparalytic snake bite patients treated with fixed dose of antisnake venom. Int J Res Med Sci 2014;2: 1676-82. https://doi.org/10.5455/2320-6012.ijrms20141182
  4. Shin Y, Jang Y, Borzee A. Snakebite envenomings in the Republic of Korea from the 1970s to the 2020s: A review. Toxicon 2021; 196:8-18. https://doi.org/10.1016/j.toxicon.2021.03.013
  5. Jackson TN, Sunagar K, Undheim EA, Koludarov I, Chan AH, Sanders K, et al. Venom down under: dynamic evolution of australian elapid snake toxins. Toxins 2013;5:2621-55. https://doi.org/10.3390/toxins5122621
  6. Davidson TM, Schafer S, Killfoil J. Cobras. Wilderness Environ Med. 1995;6:203-19. https://doi.org/10.1580/1080-6032(1995)006[0203:C]2.3.CO;2
  7. Bhattacharya P, Chakraborty A. Neurotoxic snake bite with respiratory failure. Indian J Crit Care Med 2018;11:161-4. https://doi.org/10.4103/0972-5229.35627
  8. Pawar DK, Singh H. Elapid snake bite. Br J Anaesth 1987;59: 385-7. https://doi.org/10.1093/bja/59.3.385
  9. Vital Brazil O, Vieira RJ. Neostigmine in the treatment of snake accidents caused by Micrurus Frontalis: report of two cases. Rev Inst Med Trop Sao Paulo 1996;38:61-7. https://doi.org/10.1590/S0036-46651996000100012